GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
-9.66%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$886M
AUM Growth
+$886M
(-15%)
Cap. Flow
-$82.1M
Cap. Flow
% of AUM
-9.27%
Top 10 Holdings %
Top 10 Hldgs %
70.05%
Holding
43
New
8
Increased
12
Reduced
7
Closed
10
Top Buys
| 1 |
Acadia Pharmaceuticals
ACAD
|
$31.5M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
$31.4M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$29.5M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$27M |
| 5 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$26.5M |
Top Sells
| 1 |
Iovance Biotherapeutics
IOVA
|
$78.7M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$49.3M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$41.7M |
| 4 |
DERM
Dermira, Inc.
DERM
|
$39.7M |
| 5 |
TG Therapeutics
TGTX
|
$28.3M |
Sector Composition
| 1 | Healthcare | 97.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Acadia Pharmaceuticals
ACAD
$4.38B
| $84.3M | 8.81% | 1,995,747 +745,747 | +60% | +$31.5M |
|
2
Zymeworks
ZYME
$1.12B
| $82.5M | 8.62% | 2,324,688 +100,899 | +5% | +$3.58M |
|
3
PTC Therapeutics
PTCT
$3.92B
| $78.7M | 8.22% | 1,763,387 +13,387 | +0.8% | +$597K |
|
|
4
Iovance Biotherapeutics
IOVA
$807M
| $71.5M | 7.47% | 2,387,606 -2,627,569 | -52% | -$78.7M |
|
|
CNST
5
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $62.2M | 6.49% | 1,977,502 +842,380 | +74% | +$26.5M |
|
6
United Therapeutics
UTHR
$13.8B
| $52.7M | 5.51% | 556,252 +15,073 | +3% | +$1.43M |
|
|
SAGE
7
DELISTED
Sage Therapeutics
SAGE
| $52.4M | 5.47% | 1,824,479 +1,028,422 | +129% | +$29.5M |
|
8
NextCure
NXTC
$13.5M
| $48.7M | 5.09% | 1,312,956 +178,372 | +16% | +$6.61M |
|
|
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
| $48.1M | 5.03% | 535,627 -464,373 | -46% | -$41.7M |
|
|
GWPH
10
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $39.4M | 4.12% | 450,000 +308,317 | +218% | +$27M |
|
|
ABMD
11
DELISTED
Abiomed Inc
ABMD
| $31.4M | 3.28% | +216,144 | New | +$31.4M |
|
|
MNTA
12
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $26.6M | 2.78% | 979,400 -1,811,000 | -65% | -$49.3M |
|
|
13
TG Therapeutics
TGTX
$4.65B
| $25.2M | 2.63% | 2,556,324 -2,878,459 | -53% | -$28.3M |
|
14
Prothena Corp
PRTA
$441M
| $22.3M | 2.33% | 2,082,841 -18,100 | -0.9% | -$194K |
|
|
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $19.8M | 2.07% | +581,905 | New | +$19.8M |
|
|
MYOK
16
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $17.1M | 1.78% | +364,163 | New | +$17.1M |
|
|
ARNA
17
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $16.3M | 1.7% | +387,499 | New | +$16.3M |
|
18
Abeona Therapeutics
ABEO
$350M
| $15.1M | 1.58% | 7,213,012 | – | – |
|
|
CCXI
19
DELISTED
ChemoCentryx, Inc.
CCXI
| $14.4M | 1.5% | +357,379 | New | +$14.4M |
|
|
AXNX
20
DELISTED
Axonics, Inc. Common Stock
AXNX
| $13.8M | 1.44% | 542,929 +76,422 | +16% | +$1.94M |
|
|
MTEM
21
DELISTED
Molecular Templates, Inc.
MTEM
| $11M | 1.15% | 825,000 | – | – |
|
22
Tempest Therapeutics
TPST
$44M
| $9.13M | 0.95% | 1,729,759 | – | – |
|
23
Cytokinetics
CYTK
$4.23B
| $7.83M | 0.82% | 664,097 +504,024 | +315% | +$5.94M |
|
|
VRAY
24
DELISTED
ViewRay, Inc.
VRAY
| $6.94M | 0.72% | 2,773,811 +1,058,658 | +62% | +$2.65M |
|
25
Liquidia Corp
LQDA
$2.38B
| $6.02M | 0.63% | 1,277,955 | – | – |
|